文献速递脑血管病癫痫

再灌注治疗与卒中后癫痫发作的发生率及关联:系统综述与荟萃分析

Incidence and Association of Reperfusion Therapies With Poststroke Seizures: A Systematic Review and Meta-Analysis.
PubMed 文献 · Stroke · 2020-08-10

PSS总发生率为5.9%(95%CI 4.2%-8.2%),IVT与PSS关联的汇总OR为1.24(95%CI 0.75-2.05)。

要点

  • 再灌注治疗后约1/15缺血性卒中患者出现癫痫发作。
  • PSS总发生率5.9%,IVT、机械取栓及两者联合分别为6.1%、5.9%、5.8%。
  • IVT与PSS关联的汇总OR为1.24(95%CI 0.75-2.05),无显著关联。

核心结论

  • 再灌注治疗(IVT、机械取栓或两者联合)后约1/15缺血性卒中患者出现癫痫发作。
  • 癫痫发作风险与具体再灌注治疗方式无关。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE、SCOPUS和Cochrane Library 1995年至2019年10月28日发表文献。

主要发现

  • PSS总发生率为5.9%(95%CI 4.2%-8.2%)。
  • IVT、机械取栓及两者联合的PSS发生率分别为6.1%(95%CI 3.6%-10.2%)、5.9%(95%CI 4.1%-8.4%)、5.8%(95%CI 3.0%-10.9%)。
  • 晚期PSS发生率为6.7%(95%CI 4.01%-11.02%),早期PSS发生率为3.14%(95%CI 2.05%-4.76%)。
  • IVT与PSS关联的汇总OR为1.24(95%CI 0.75-2.05)。

关键数值与推荐

  • PSS总发生率5.9%(95%CI 4.2%-8.2%)。
  • IVT相关PSS发生率6.1%(95%CI 3.6%-10.2%),机械取栓5.9%(95%CI 4.1%-8.4%),联合治疗5.8%(95%CI 3.0%-10.9%)。
  • 早期PSS发生率3.14%(95%CI 2.05%-4.76%),晚期PSS发生率6.7%(95%CI 4.01%-11.02%)。
  • IVT与PSS关联的汇总OR为1.24(95%CI 0.75-2.05)。

临床怎么用

  • 再灌注治疗后应关注卒中后癫痫发作,尤其约1/15患者可能发生。
  • IVT与PSS关联无统计学意义,无需因癫痫风险改变再灌注决策。

局限性

  • 报告机械取栓单独或联合IVT与PSS风险的研究少于3项,无法计算该治疗与癫痫发作风险的估计值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: We performed a systematic review and meta-analysis to assess the incidence and risk of seizures following acute stroke reperfusion therapy (intravenous thrombolysis [IVT] with r-tPA [recombinant tissue-type plasminogen activator], mechanical thrombectomy or both). METHODS: We searched major databases (MEDLINE, SCOPUS, and Cochrane Library) for articles published between 1995 and October 28, 2019. The primary outcome was the overall and treatment specific pooled incidence of poststroke seizures (PSS) following acute reperfusion therapy. We also computed the pooled incidence of early poststroke seizures and late poststroke seizures separately for all studies. We derived the risk of PSS associated with IVT in the pooled cohort of patients who received only IVT. The small number of studies (<3) that reported on the risk of PSS associated with mechanical thrombectomy alone or in combination with IVT did not allow us to compute an estimate of the risk of seizures associated with this therapy. RESULTS: We identified 13 753 patients with stroke, of which 592 had seizures. The pooled incidence of PSS was 5.9 % (95% CI, 4.2%-8.2%). PSS incidence rates among patients with stroke treated with IVT, mechanical thrombectomy, and both were respectively 6.1% (95% CI, 3.6%-10.2%), 5.9% (95% CI, 4.1%-8.4%), and 5.8 % (95% CI, 3.0%-10.9%). The incidence of late PSS was 6.7% (95% CI, 4.01%-11.02%) and that of early PSS was 3.14% (95% CI, 2.05%-4.76%). The pooled odds ratio for the association between IVT and PSS was 1.24 (95% CI, 0.75-2.05). CONCLUSIONS: The findings of this meta-analysis suggest that about one in 15 ischemic stroke patients treated with IVT, mechanical thrombectomy, or both develop seizures independently of the specific reperfusion treatment that they received.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Lekoubou A, Fox J, Ssentongo P, et al. Incidence and Association of Reperfusion Therapies With Poststroke Seizures: A Systematic Review and Meta-Analysis. Stroke. 2020. PMID: 32772682. doi:10.1161/STROKEAHA.119.028899

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。